Structure–activity relationship of GPR15L peptide analogues and investigation of their interaction with the GPR15 receptor
Basic & Clinical Pharmacology & Toxicology · 2023
DOI: 10.1111/bcpt.13861 ↗Kurz gefasst
Fachartikel in der Zeitschrift Basic & Clinical Pharmacology & Toxicology, 2023. Verfasst von Yufang Deng und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Drug Design and Pharmacology, Faculty of Health and Medical Sciences, University of Copenhagen, 2100, Copenhagen, Denmark. Hauptthemen laut MEDLINE: Receptors, G-Protein-Coupled, Peptides. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: European Research Council, H2020 European Research Council, China Scholarship Council.
Abstract (Originalsprache)
The 57‐mer full‐length GPR15L(25‐81) peptide has been identified as the principal endogenous agonist of the G protein‐coupled receptor GPR15. Its main activity resides in the C‐terminal 11‐mer GPR15L(71‐81), which has full efficacy but ~40‐fold lower potency than the full‐length peptide. Here, we systematically investigated the structure–activity relationship of GPR15L(71‐81) by truncations/extensions, alanine‐scanning, and N‐ and C‐terminal capping. The synthesized peptide analogues were tested at GPR15 stably expressed in HEK293A cells using a homogenous time‐resolved Förster resonance energy transfer‐based G i cAMP functional assay. We show that the C‐terminal α carboxyl group and the residues Leu 78 , Pro 75 , Val 74 , and Trp 72 are critical for receptor interaction and contribute significantly to the peptide potency. Furthermore, we tested the ability of GPR15L(71‐81), C‐terminally amidated GPR15L(71‐81), and GPR15L(25‐81) to activate the three GPR15 receptor mutants in a bioluminescence resonance energy transfer‐based G protein activation assay. The results demonstrate that the Lys192 and Glu272 residues in GPR15 are important for the potency of the GPR15L peptide. Overall, our study identifies critical residues in the peptide and receptor sequences for future drug design.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Drug Design and Pharmacology, Faculty of Health and Medical Sciences, University of Copenhagen, 2100, Copenhagen, Denmark.
ORCID-Profile: Claudia V Perez Almeria, Hans Bräuner-Osborne
Förderung
- European Research Council
- H2020 European Research Council
- China Scholarship Council
- Novo Nordisk Fonden
- Carlsbergfondet
- Lundbeckfonden
Zitieren
APA
Deng, Y., Perez Almeria, C. V., van Gijzel, L., Schaller, K., Vedel, L., Gloriam, D. E., Ulven, T., & Bräuner-Osborne, H. (2023). Structure–activity relationship of GPR15L peptide analogues and investigation of their interaction with the GPR15 receptor. Basic & Clinical Pharmacology & Toxicology. https://doi.org/10.1111/bcpt.13861
Vancouver
Deng Y, Perez Almeria CV, van Gijzel L, Schaller K, Vedel L, Gloriam DE, et al. Structure–activity relationship of GPR15L peptide analogues and investigation of their interaction with the GPR15 receptor. Basic & Clinical Pharmacology & Toxicology. 2023. doi:10.1111/bcpt.13861
BibTeX
@article{Deng2023,
author = {Deng, Yufang and Perez Almeria, Claudia V and van Gijzel, Lieke and Schaller, Kay and Vedel, Line and Gloriam, David E and Ulven, Trond and Bräuner-Osborne, Hans},
title = {Structure–activity relationship of GPR15L peptide analogues and investigation of their interaction with the GPR15 receptor},
journal = {Basic & Clinical Pharmacology & Toxicology},
year = {2023},
doi = {10.1111/bcpt.13861}
}
EUVIMED